Premium
Functional analysis of two rare CYP21A2 mutations detected in Italian patients with a mildest form of congenital adrenal hyperplasia
Author(s) -
Concolino Paola,
Vendittelli Francesca,
Mello Enrica,
Minucci Angelo,
Carrozza Cinzia,
Rossodivita Aurora,
Giardina Bruno,
Zuppi Cecilia,
Capoluongo Ettore
Publication year - 2009
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.2008.03517.x
Subject(s) - congenital adrenal hyperplasia , missense mutation , 21 hydroxylase , allele , genetics , mutation , biology , gene , endocrinology , mutant , medicine
Summary Background More than 90% of all cases of congenital adrenal hyperplasia (CAH) result from steroid 21‐hydroxylase gene ( CYP21A2 ) mutations. Most of these mutations result from intergenic recombinations between CYP21A2 and closely linked CYP21A1P pseudogene. Rare mutations not generated by gene conversion account for 5–10% of 21‐hydroxylase deficiency alleles. Objective Functional analysis of two novel CYP21A2 missense mutations (p.R224W and p.D407N) was performed. Design Our study was composed of two Italian patients suffering from a very mild form of nonclassic CAH (NC‐CAH). To assay the enzymatic activity of mutants, the in vitro analysis was performed in transiently transfected COS‐1 cells. Results The residual activities obtained for p.R224W and p.D407N mutants allow their classification as NC‐CAH mutations. These results correlate with the rate of severity of the patients’ disease. Conclusions In this paper, we report two novel CYP21A2 mutations in two Italian individuals affected by 21‐hydroxylase deficiency. Based on the functional in vitro analysis we can classify these mutations as NC‐CAH variants.